ProKidney Corp. (PROK)
Largest Insider Buys in Sector
PROK Stock Price History Chart
PROK Stock Performance
About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Insider Activity of ProKidney Corp.
Over the last 12 months, insiders at ProKidney Corp. have bought $74.99M and sold $394,541 worth of ProKidney Corp. stock.
On average, over the past 5 years, insiders at ProKidney Corp. have bought $37.53M and sold $10.63M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Legorreta Pablo G. () — $109.47M. Control Empresarial de Capitales S.A. de C.V. (Add'l Rep. Persons-see Ex.99-1) — $60.75M.
The last purchase of 22,617,909 shares for transaction amount of $54.74M was made by Legorreta Pablo G. () on 2024‑06‑13.
List of Insider Buy and Sell Transactions, ProKidney Corp.
| 2024-09-19 | Sale | Chief Regulatory Officer | 16,412 0.007% | $2.50 | $41,030 | -23.01% | ||
| 2024-07-26 | Sale | Chief Regulatory Officer | 826 0.0004% | $2.50 | $2,065 | -18.37% | ||
| 2024-06-18 | Sale | Chief Regulatory Officer | 17,238 0.0083% | $2.82 | $48,616 | -21.64% | ||
| 2024-06-13 | 22.62M 9.3818% | $2.42 | $54.74M | -28.62% | ||||
| 2024-06-11 | Add'l Rep. Persons-see Ex.99-1 | 8.26M 3.4281% | $2.42 | $20M | -11.78% | |||
| 2024-05-20 | Sale | Chief Regulatory Officer | 17,238 0.0121% | $4.08 | $70,386 | -43.56% | ||
| 2024-04-22 | Sale | SVP of Regulatory Development | 16,438 0.0071% | $2.51 | $41,315 | -18.38% | ||
| 2024-04-18 | Sale | SVP of Regulatory Development | 800 0.0003% | $2.54 | $2,028 | -7.50% | ||
| 2024-04-16 | Sale | SVP of Regulatory Development | 17,238 0.0074% | $2.50 | $43,095 | -18.01% | ||
| 2024-04-12 | Sale | SVP of Regulatory Development | 84,103 0.0249% | $1.73 | $145,498 | +27.43% | ||
| 2024-04-01 | Sale | SVP of Regulatory Development | 300 <0.0001% | $1.69 | $507 | +37.81% | ||
| 2024-03-25 | Add'l Rep. Persons-see Ex.99-1 | 30,000 0.0074% | $1.43 | $42,954 | +52.08% | |||
| 2024-03-22 | Add'l Rep. Persons-see Ex.99-1 | 14,000 0.0034% | $1.40 | $19,586 | +56.43% | |||
| 2024-03-20 | Add'l Rep. Persons-see Ex.99-1 | 33,000 0.0079% | $1.40 | $46,111 | +49.32% | |||
| 2024-03-14 | Add'l Rep. Persons-see Ex.99-1 | 50,000 0.0116% | $1.36 | $67,925 | +60.29% | |||
| 2024-03-13 | Add'l Rep. Persons-see Ex.99-1 | 50,000 0.0129% | $1.50 | $75,090 | +46.31% | |||
| 2023-11-19 | Sale | 2.07M 0.4651% | $1.31 | $2.71M | +9.09% | |||
| 2023-11-17 | Sale | 10 percent owner | 258,400 0.0529% | $1.19 | $308,400 | +59.09% | ||
| 2023-11-16 | Sale | 10 percent owner | 212,100 0.0445% | $1.22 | $259,398 | +56.10% | ||
| 2023-11-15 | Sale | 10 percent owner | 282,300 0.072% | $1.49 | $420,147 | +38.13% |
Insider Historical Profitability
| Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 71560107 24.5313% | $1.51 | 6 | 0 | |
| Legorreta Pablo G. | 22617909 7.7536% | $1.51 | 1 | 0 | ||
| Cowen Aaron | 10 percent owner | 6280175 2.1529% | $1.51 | 3 | 0 | +26.12% |